文献速递炎症性肠病

乙醛代谢负荷改变饮酒对炎症性肠病易感性的影响

Combined acetaldehyde metabolism burden modifies IBD susceptibility to alcohol consumption.
PubMed 文献 · Gut · 2026-06-17

一项前瞻性队列研究(n=455 417)分析饮酒与IBD风险关联,并构建乙醛负荷评分检验效应修饰。低负荷者红葡萄酒摄入每增加1个标准差与克罗恩病风险降低20%相关,高负荷者风险增加38%。遗传、代谢组及动物和类器官实验支持乙醛有害、乙酸盐保护。

要点

  • 饮酒与IBD风险的关联受乙醛代谢负荷修饰。
  • 低乙醛负荷者红葡萄酒摄入与克罗恩病风险降低相关。
  • 高乙醛负荷者红葡萄酒摄入与克罗恩病风险增加相关。

核心结论

  • 乙醛代谢负荷修饰饮酒相关的IBD易感性,精准预防需考虑个体酒精代谢差异。

研究设计与样本

  • 前瞻性队列研究纳入455 417人,用Cox比例风险回归分析饮酒与IBD风险关联。
  • 构建乙醛负荷评分,基于经表达数量性状位点和蛋白质组数据验证的酒精脱氢酶和醛脱氢酶遗传变异。
  • 开展遗传和代谢组分析,以及小鼠和人类结肠类器官实验以加强因果推断。

主要发现

  • 饮酒与IBD风险的负相关主要归因于红葡萄酒。
  • 低负荷个体中,红葡萄酒摄入每增加1个标准差(相当于每周59.4克纯酒精)与克罗恩病风险降低20%(95%CI 7%至31%)相关。
  • 高负荷个体中,红葡萄酒摄入每增加1个标准差与克罗恩病风险增加38%(95%CI 13%至70%)相关。
  • 遗传和代谢组分析揭示乙醛的有害效应和乙酸盐的保护效应。
  • 体内和体外实验证实上述效应,调节醛脱氢酶活性显著改变结肠炎结局。

临床怎么用

  • 评估IBD风险或制定预防策略时,应考虑个体酒精代谢能力,尤其是乙醛负荷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effect of alcohol consumption on IBD remains inconclusive, potentially due to the overlooked role of alcohol metabolism. OBJECTIVE: We aimed to investigate the potential modifying role of alcohol metabolic capacity in the associations. DESIGN: A prospective cohort study (n=455 417) was used for association analysis between alcohol consumption and IBD risk using Cox proportional hazards regression. An acetaldehyde burden score, using genetic variants of alcohol dehydrogenase and aldehyde dehydrogenase validated by expression quantitative trait loci and proteomic data, was constructed to test effect modification. Genetic and metabolomic analyses, along with mice and human-derived colonic organoid experiments, were conducted to strengthen causal inference. RESULTS: The inverse association between alcohol and IBD risk was mainly attributable to red wine. Among individuals with low burden, reflecting low acetaldehyde generation and high acetaldehyde metabolism, per SD increase in red wine consumption (equivalent to 59.4 g/week of pure alcohol intake) was associated with a 20% (95% CI 7% to 31%) reduced Crohn's disease risk, whereas a 38% (95% CI 13% to 70%) increased risk among those with high burden. Genetic and metabolomic analyses further revealed harmful effects of acetaldehyde and protective effects of acetate. In vivo and in vitro experiments further confirmed these effects and showed that modulation of aldehyde dehydrogenase activity significantly altered colitis outcomes. CONCLUSION: Acetaldehyde metabolism burden modifies susceptibility to alcohol-related IBD and emphasises the importance of considering individual differences in alcohol metabolism when developing precision prevention strategies for IBD.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Chen J, Guo Y, Hu J, et al. Combined acetaldehyde metabolism burden modifies IBD susceptibility to alcohol consumption. Gut. 2026. PMID: 42309807. doi:10.1136/gutjnl-2026-338262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。